Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
INSP

INSP - Inspire Medical Systems Inc Stock Price, Fair Value and News

$82.06+0.27 (+0.33%)
Market Closed

70/100

INSP

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

70/100

INSP

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$98.46

Target 3M

$83.77

Target 6M

$88.37

INSP Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

INSP Price Action

Last 7 days

-14.7%

Last 30 days

-12.4%

Last 90 days

12.3%

Trailing 12 Months

-57.4%

INSP RSI Chart

INSP Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

INSP Valuation

Market Cap

2.4B

Price/Earnings (Trailing)

53.51

Price/Sales (Trailing)

2.7

EV/EBITDA

53.89

Price/Free Cashflow

24.13

INSP Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$98.46

Target 3M

$83.77

Target 6M

$88.37

INSP Fundamentals

INSP Revenue

Revenue (TTM)

882.6M

Rev. Growth (Yr)

10.49%

Rev. Growth (Qtr)

3.42%

INSP Earnings

Earnings (TTM)

44.6M

Earnings Growth (Yr)

-46.3%

Earnings Growth (Qtr)

376.5%

INSP Profitability

Operating Margin

98.42%

EBT Margin

5.89%

Return on Equity

6.69%

Return on Assets

5.52%

Free Cashflow Yield

4.14%

INSP Investor Care

Buy Backs (1Y)

3.04%

Diluted EPS (TTM)

1.48

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025840.1M861.3M882.6M0
2024660.9M705.7M755.6M802.8M
2023466.4M526.1M570.2M624.8M
2022262.4M300.9M348.4M407.9M
2021134.4M175.2M201.0M233.4M
202087.1M81.3M96.3M115.4M
201956.8M63.9M71.7M82.0M
201833.3M38.2M44.0M50.6M
201719.5M22.5M25.5M28.6M
201600016.4M
Get all data in R, Python etc through our Historical Stock Data APIs

About Inspire Medical Systems Inc

INSP
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
 CEO
 WEBSITEinspiresleep.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES755

Inspire Medical Systems Inc Frequently Asked Questions

INSP is the stock ticker symbol of Inspire Medical Systems Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Inspire Medical Systems Inc is 2.38 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check INSP's fair value in chart for subscribers.

The fair value guage provides a quick view whether INSP is over valued or under valued. Whether Inspire Medical Systems Inc is cheap or expensive depends on the assumptions which impact Inspire Medical Systems Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for INSP.

As of Wed Jan 28 2026, INSP's PE ratio (Price to Earnings) is 53.51 and Price to Sales (PS) ratio is 2.7. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. INSP PE ratio will change depending on the future growth rate expectations of investors.